Sustainability In Bacterial Endotoxin Testing – A Holistic Approach – Part II

Previously Aired on May 13th, 2021

Sign Up:

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

  Register

Overview

Continuing the discussion from late 2020, Veronika will provide an update on the developing situation around the use of recombinant reagents for the Bacterial Endotoxin Test and help you navigate the local validation requirements.

Veronika will also share additional comparability data demonstrating the performance of recombinant technologies versus the gold standard test – LAL based reagents.

Brett will provide more detail on horseshoe crab stock status, horseshoe crab conservation efforts including ACC’s aquaculture system and the 2021 milestone. Brett will also provide insight and share facts regarding the impact of COVID-19 vaccine production on LAL supply and horseshoe crab populations.

In this webinar you’ll learn:

  • News developments in recombinant technologies
  • Update on the regulatory framework around recombinant reagents
  • Sharing comparability data
  • Most current conservation/sustainability status of the horseshoe crab population in the US
Who Should Attend:
  • Senior Microbiologists
  • Lead Scientists
  • Laboratory Managers
  • QA Specialists
  • Heads of Quality 

Presenters

Presenter
Veronika Wills
Associate Director, Global Technical Services,
Associates of Cape Cod, Inc. (ACC)
View Biography
Presenter
Brett Hoffmeister
(Presenter)
LAL Production Manager,
Associates of Cape Cod, Inc. (ACC)
View Biography
Presenter
Mike Auerbach
(Moderator)
Editor-in-Chief,
American Pharmaceutical Review